Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

Monopar Therapeutics (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative cancer treatments, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. Chandler D. Robinson, MD, Monopar's CEO, will present at the conference. Key details include:

• Presentation will be webcast starting Monday, September 9, 2024 at 7:00 a.m. ET
• In-person one-on-one meetings will be held at the Lotte New York Palace, NY
• Conference dates: September 9 - 11, 2024

This event provides Monopar an opportunity to showcase its progress and connect with potential investors, potentially impacting its stock performance (MNPR).

WILMETTE, Ill., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that Chandler D. Robinson, MD, Monopar’s Chief Executive Officer, will present at the H.C. Wainwright 26^th Annual Global Investment Conference. The Company’s presentation will be webcast beginning on Monday, September 9, 2024 at 7:00 a.m. ET. In person one-on-one meetings will take place at the Lotte New York Palace, NY, NY from September 9 - 11, 2024.

About Monopar Therapeutics Inc.

Monopar Therapeutics is a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, including Phase 1-stage MNPR-101-Zr for imaging advanced cancers, Phase 1-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac225 for the treatment of advanced cancers, as well as early development stage programs against solid cancers. For more information, visit: www.monopartx.com.

CONTACT:  

Monopar Therapeutics Inc.
Investor Relations  
Karthik Radhakrishnan
Chief Financial Officer
karthik@monopartx.com

Follow Monopar on social media for updates: 
Twitter: @MonoparTx  LinkedIn: Monopar Therapeutics

FAQ

When is Monopar Therapeutics (MNPR) presenting at the H.C. Wainwright Global Investment Conference?

Monopar Therapeutics (MNPR) will present at the H.C. Wainwright 26th Annual Global Investment Conference on Monday, September 9, 2024 at 7:00 a.m. ET.

Where will the in-person meetings for Monopar Therapeutics (MNPR) take place during the conference?

The in-person one-on-one meetings for Monopar Therapeutics (MNPR) will take place at the Lotte New York Palace in New York, NY.

What are the dates for the H.C. Wainwright Global Investment Conference that Monopar Therapeutics (MNPR) is attending?

The H.C. Wainwright 26th Annual Global Investment Conference, which Monopar Therapeutics (MNPR) is attending, will be held from September 9 to 11, 2024.

Who will be presenting on behalf of Monopar Therapeutics (MNPR) at the investment conference?

Chandler D. Robinson, MD, the Chief Executive Officer of Monopar Therapeutics (MNPR), will be presenting at the H.C. Wainwright 26th Annual Global Investment Conference.